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Functional neurological disorder (FND), is the second most common reason for 
referral to a neurologist. Despite being potentially treatable, FND remains 
underdiagnosed and associated with high levels of disability and distress. In this 
article, we address ten common myths about FND that continue to obstruct the 
diagnosis and treatment for these patients, and present them with accompanying 
lessons for the clinician. 
Myth 1: FND is a diagnosis of exclusion
The diagnosis of FND should be approached in the same way as other medical 
conditions and be diagnosed using positive features, rather than by ruling out other 
conditions.(1) Positive signs on examination include Hoover’s sign of functional limb 
weakness, where hip extension weakness returns to normal when attention is 
diverted to the contralateral leg. Functional tremor may ‘entrain’ to the frequency of 
imposed rhythmic movements in another body part. Functional (dissociative) 
seizures can be recognised by a combination of typical features such as eyes tightly 
closed during an episode, long duration, or awareness of generalized shaking. Thus, 
the diagnosis of FND should be based primarily on typical features only seen in this 
disorder or internal inconsistency of the symptoms and signs.(2) 
Lesson: The diagnosis of FND should be “ruled in” based on the presence of positive 
signs.
Myth 2: Patients have either FND or another neurological disorder
The presence of another neurological condition is a powerful risk factor for the 
development of FND and they commonly occur together. Physical injury, surgical 
procedures and migraine often precipitate functional movements in vulnerable 
individuals, and up to 20% of patients with functional (dissociative) seizures also 
have epilepsy.(3) Some conditions like Parkinson’s disease appear particularly likely 
to present with comorbid FND, perhaps because of shared neurobiology, but 
symptoms and disability from any neurological condition may be sufficient. For this 
reason, there should be a low threshold for investigations. 
Lesson: FND commonly co-occurs with other neurological disorders.
Myth 3: A bizarre presentation indicates FND
FND is frequently equated to bizarre or unrecognizable clinical neurological 
presentations, such as complex movement disorders. In fact, several genetic or 
acquired movement disorders present with strikingly bizarre phenomenology.(4–6)  
In such cases, the “bizarreness” is not the key to the diagnosis, but rather it is that 
the bizarre pattern remains consistently present, despite variations in task 
performance, or with distraction. Conversely, the key to recognizing FND is the 
variability of the symptoms and signs across different situations over time and within 
the physical examination itself. In addition, in the case of functional movement 
disorders, the movements are not inherently more bizarre, they just abide by their 
own rules, and therefore can also produce recognizable phenotypes. For example, 
functional facial dystonia is remarkably identical amongst patients.(7) 































































Lesson: A bizarre presentation does not equate to a diagnosis of FND.
Myth 4: Different phenotypes of FND indicate different disorders
Various presentations of FND are commonly defined as the functional correlates of 
known neurological signs, e.g. a functional tremor, dystonia, seizures, etc. However, 
given the shared risk factors among patients with FND, it is more likely that these 
different phenotypes represent a variable expression of the same underlying 
disorder (FND), manifesting differently in different individuals. FND is often 
accompanied by the presence of pain, fatigue, cognitive symptoms, and/or other 
systemic functional symptoms. Recognizing this broader FND syndrome can be 
helpful diagnostically in challenging cases, particularly in complex presentations that 
do not neatly conform to known phenotypes. 
Lesson: Functional symptoms are often part of a broader FND syndrome including 
pain, fatigue, and cognitive symptoms.
Myth 5. FND symptoms are voluntary 
FND symptoms do arise from the voluntary nervous system which is one reason why 
concerns about exaggeration or malingering persist in many doctor’s minds when 
thinking about FND. Multiple convergent evidence suggests that feigning is a highly 
improbable reason for these symptoms including studies showing dysfunction of 
brain regions involved in movement planning, attention, body monitoring and sense 
of agency in patients with FND, in contrast with observations in experimental 
feigning.(14,17,18) Neurophysiological studies, differential recovery in randomised 
trials, and consistent presentations and comorbidities across cultures and across 
time are all supportive of FND as a distinct clinical brain disorder, and not a result of 
voluntary feigning of symptoms.
Lesson: FND symptoms are involuntary; patients are not “putting them on” and 
feigning is rare.
Myth 6: There is no role for investigations in the diagnosis of FND
Having a low threshold for investigations is important because additional 
neurological disease, such as radiculopathy or demyelination, is such a strong risk 
factor for FND. Care must be taken in explaining to patients why investigations are 
being done and to prepare the patient for potentially incidental findings. Laboratory-
supported criteria can also be helpful in difficult cases, such as the presence of a 
cortical Bereitschaftspotential in functional myoclonus which suggests use of self-
initiated movement pathways. Electromyography can be useful in detecting positive 
signs such as coherence, distractibility or entrainment in functional tremor, which 
can then be demonstrated to the patient. Video electroencephalography is helpful in 
differentiating epileptic and functional (dissociative) seizures. Ideally, the FND 
diagnosis is presented before the outcome of the investigations to highlight that it is 
a ‘rule-in’ diagnosis. 































































Lesson: Investigations can be useful to identify co-morbid neurological conditions, 
diagnose phenotypically challenging cases, and reinforce positive signs to the 
patient.
Myth 7: There is less harm in missing a diagnosis of FND than missing another 
neurological disease
There is often the perception that it is worse to miss a diagnosis of another 
neurological disease than a functional disorder. Published frequencies of 
misdiagnosing FND has been consistently around 4% from the early 1970s to 2005, 
similar to other neurological and psychiatric disorders, with even lower rates in more 
recent studies(8). To put this into perspective, the rate of misdiagnosis of Parkinson’s 
disease in tertiary centres is approximately 25%, at least upon the initial 
contact.(9,10) It is appropriate to be concerned about missing any diagnosis, 
particularly in young and disabled patients, and especially when potentially treatable 
like FND. Misdiagnosis of patients with FND with diseases such as multiple sclerosis 
occurs just as commonly and can lead to just as much harm.(11,12) 
Lesson: FND is not misdiagnosed more than other conditions. Erroneously 
diagnosing FND as another neurological condition can be as harmful as the reverse.
Myth 8: FND is exclusively a psychological problem caused by psychological factors
For much of the 20th century Freud’s conversion hypothesis – that FND arises from a 
psychological conflict converted into physical symptoms – has been dominant. More 
recent work shows that a history of adverse life experience and psychological 
comorbidities are commonly seen in this population, but they do not occur in all 
patients, and even when present may not be relevant.(13) This is now reflected in 
the DSM-5 diagnostic criteria which no longer requires the patient to have a 
psychological stressor.(14) In addition psychological/psychiatric comorbidities are 
also common in other neurological disorders.(15–17) Just as hypertension and 
smoking are risk factors for stroke – disease comorbidity, health anxiety and stress 
are risk factors for FND. FND is a complex and heterogeneous disorder, with multiple 
potential biological and psychological causes and mechanisms that vary hugely 
between patients and which challenges conventional dualistic assumptions about 
the brain and mind. 
Lesson: Psychological factors are one of many possible risk factors for FND and 
should not be considered the sole etiological cause.
Myth 9: The prognosis of FND is usually good 
There tends to be a perception that in FND ‘nothing is wrong’ or that, with 
treatment, all patients ought to improve. As in any neurological condition, there is a 
spectrum of disease severity treatment response but many studies show the 
majority of patients being the same or worse at follow-up.(8) Patients with FND have 
levels of disability and impairment in quality of life similar to those with similar 
debilitating conditions such as Parkinson’s disease or epilepsy(18) which commonly 
includes chronic pain, fatigue, cognitive problems and psychological comorbidity. 































































Lesson: Patients with FND are as disabled and have as impaired quality of life as 
patients with other neurological conditions. When left untreated, prognosis is 
unfavourable for most.
Myth 10: The treatment of FND is solely referral to a psychologist or psychiatrist
FND patients require individualized treatment, beginning with a transparent and 
carefully explained diagnosis. This should avoid simply telling the patient what they 
don’t have or jumping to conclusions about aetiology. Demonstration of positive 
signs to the patient can alter fundamental views about the nature and potential 
reversibility of the condition. As in other neurological conditions a multidisciplinary 
approach is often required for more complex cases.(19) Physical therapy alone is 
effective in some patients with functional movement disorders and has promising 
early data from randomised trials, even in patients with long duration 
symptoms.(20) There is an evidence base for psychological therapy in functional 
(dissociative) seizures(21) which may also be essential when anxiety, mood, or 
personality disorders are comorbid. Identifying and triaging patients with dominant 
pain or fatigue syndromes is important, as these may need to be the initial focus of 
treatment. In some severe cases, the main treatment focus may be on support and 
prevention of iatrogenic harm from unnecessary medication or interventions.
Lesson: FND treatment is individualized and involves careful explanation 
combinations of physical and psychological rehabilitation.
Conclusion
FND is a common condition, lying at the interface of neurology and psychiatry. A 
clear diagnosis delivered in a timely manner can have a strong positive impact on the 
patient’s symptoms, prognosis, and quality of life. Patients can improve with 
individualized, multidisciplinary treatment. Attitudes and practices are changing but 
the many misconceptions that surround FND continue to obstruct good medical care 
for these patients. 
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Functional neurological disorder (FND), is the second most common reason for 
referral to a neurologist. Despite being potentially treatable, FND remains 
underdiagnosed and associated with high levels of disability and distress. In this 
article, we address ten common myths about FND that continue to obstruct the 
diagnosis and treatment for these patients, and present them with accompanying 
lessons for the clinician. 
Myth 1: FND is a diagnosis of exclusion
The diagnosis of FND should be approached in the same way as other medical 
conditions and be diagnosed using positive features, rather than by ruling out other 
conditions.(1) Positive signs on examination include Hoover’s sign or abductor sign 
of functional limb weakness, where hip extension weakness returns to normal when 
attention is diverted to the contralateral leg. Functional tremor may ‘entrain’ to the 
frequency of imposed rhythmic movements in another body part. Functional 
(dissociative) seizures can be recognised by a combination of typical features such as 
eyes tightly closed during an episode, long duration, or awareness of generalized 
shaking. Thus, the diagnosis of FND should be based primarily on typical features 
only seen in this disorder or internal inconsistency of the symptoms and signs.(2) 
Lesson: The diagnosis of FND should be “ruled in” based on the presence of positive 
signs.
Myth 2: Patients have either FND or another neurological disorder
The presence of another neurological condition is a powerful risk factor for the 
development of FND and they commonly occur together. Physical injury, surgical 
procedures and migraine often precipitate functional movements in vulnerable 
individuals, and up to 20% of patients with functional (dissociative) seizures also 
have epilepsy.(3) Some conditions like Parkinson’s disease appear particularly likely 
to present with comorbid FND, perhaps because of shared neurobiology, but 
symptoms and disability from any neurological condition may be sufficient. For this 
reason, there should be a low threshold for investigations. 
Lesson: FND commonly co-occurs with other neurological disorders.
Myth 3: A bizarre presentation indicates FND
FND is frequently equated to bizarre or unrecognizable clinical neurological 
presentations, such as complex movement disorders. In fact, several genetic or 
acquired movement disorders present with strikingly bizarre phenomenology.(4–6)  
In such cases, the “bizarreness” is not the key to the diagnosis, but rather it is that 
the bizarre pattern remains consistently present, despite variations in task 
performance, or with distraction. Conversely, the key to recognizing FND is the 
variability of the symptoms and signs across different situations over time and within 
the physical examination itself. In addition, in the case of functional movement 
disorders, the movements are not inherently more bizarre, they just abide by their 
own rules, and therefore can also produce recognizable phenotypes. For example, 
functional facial dystonia is remarkably identical amongst patients.(7) 































































Lesson: A bizarre presentation does not equate to a diagnosis of FND.
Myth 4: Different phenotypes of FND indicate different disorders
Various presentations of FND are commonly defined as the functional correlates of 
known neurological signs, e.g. a functional tremor, dystonia, seizures, etc. However, 
given the shared risk factors among patients with FND, it is more likely that these 
different phenotypes represent a variable expression of the same underlying 
disorder (FND), manifesting differently in different individuals. FND is often 
accompanied by the presence of pain, fatigue, cognitive symptoms, and/or other 
systemic functional symptoms. Recognizing this broader FND syndrome can be 
helpful diagnostically in challenging cases, particularly in complex presentations that 
do not neatly conform to known phenotypes. 
Lesson: Functional symptoms are often part of a broader FND syndrome including 
pain, fatigue, and cognitive symptoms.
Myth 5. FND symptoms are voluntary 
FND symptoms are perceived as involuntary butdo arise from the voluntary nervous 
system which is one reason why concerns about exaggeration or malingering persist 
in many doctor’s minds when thinking about FND. Multiple convergent evidence 
suggests that feigning is a highly improbable reason for these symptoms including 
studies showing dysfunction of brain regions involved in movement planning, 
attention, body monitoring and sense of agency in patients with FND, which in 
contrastvary with those seenobservations in experimental feigning.(14,17,18) 
Neurophysiological studies, differential recovery in randomised trials, and consistent 
presentations and comorbidities across cultures and across tim  are all supportive of 
FND as a distinct clinical brain disorder, and not a result of voluntary feigning of 
symptoms.
Lesson: FND symptoms are involuntary; patients are not “putting them on” and 
feigning is rare.
Myth 6: There is no role for investigations in the diagnosis of FND
Investigations can be useful in establishing a diagnosis of FND. Having a low 
threshold to do sofor investigations is reasonable important because as mentioned, 
additional neurological disease, such as radiculopathy or demyelination, is such a 
strong risk factor for FND. Imaging should be done primarily to look for the presence 
of additional neurological disease, such as radiculopathy or demyelination. Care 
must be taken in how investigations are framed to the patient, since they do not 
change the diagnosis of FNDin explaining to patients why investigations are being 
done and to prepare the patient for potentially incidental findings, or in the event 
that incidental findings are discovered. such as the clinically silent multiple sclerosis 
or root lesion contributing to the clinical picture. Having a low threshold to do so is 
reasonable because as mentioned, neurological disease is such a strong risk factor 
for FND. Laboratory-supported criteria can also be helpful in difficult cases, such as 
the presence of a cortical Bereitschaftspotential in functional myoclonus which 
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suggests use of self-initiated movement pathways. Electromyography can be useful 
in detecting positive signs such as coherence, distractibility or entrainment in 
functional tremor, which can then be demonstrated to the patient. Video 
electroencephalography is helpful in differentiating epileptic and functional 
(dissociative) seizures. Ideally, the FND diagnosis is presented before the outcome of 
the investigations to highlight that it is a ‘rule-in’ diagnosis. 
Lesson: Investigations can be useful to identify co-morbid neurological conditions, 
diagnose phenotypically challenging cases, and reinforce positive signs to the 
patient.
Myth 7: There is less harm in missing a diagnosis of FND than missing another 
neurological disease
There is often the perception that it is worse to miss a diagnosis of another 
neurological disease than a functional disorder. Published frequencies of 
misdiagnosing FND has been consistently around 4% from the early 1970s to 2005, 
similar to other neurological and psychiatric disorders, with even lower rates in more 
recent studies(8). To put this into perspective, the rate of misdiagnosis of Parkinson’s 
disease in tertiary centres is approximately 25%, at least upon the initial 
contact.(9,10) It is appropriate to be concerned about missing any diagnosis, 
particularly in young and disabled patients, and especially when potentially treatable 
like FND. Misdiagnosis of patients with FND with diseases such as multiple sclerosis 
occurs just as commonly and can lead to just as much harm.(11,12) 
Lesson: FND is not misdiagnosed more than other conditions. Erroneously 
diagnosing FND as another neurological condition can be as harmful as the reverse.
Myth 8: FND is exclusively a psychological problem caused by psychological factors
For much of the 20th century Freud’s conversion hypothesis -– that FND arises from 
is a psychological conflict converted into physical symptoms – has been dominant. 
More recent work shows that a history of adverse life experience and psychological 
comorbidities are commonly seen in this population, but they do not occur in all 
patients, and even when present may not be relevant.(132) This is now reflected in 
the DSM-5 diagnostic criteria which no longer requires the patient to have a 
psychological stressor.(143) In addition psychological/psychiatric comorbidities are 
also common in other neurological disorders.(154–176) Just as hypertension and 
smoking are risk factors for stroke – disease comorbidity, health anxiety and stress 
are risk factors for FND. FND is a complex and heterogenous neuropsychiatric 
disorder, best approached from a biopsychosocial perspective with predisposing, 
precipitating and perpetuating factors with multiple potential biological and 
psychological causes and mechanisms that vary hugely between patients and which 
challenges conventional dualistic assumptions about the brain and mind. 
Lesson: Psychological factors are one of many possible risk factors for FND and 
should not be considered the sole etiological cause.
Myth 9: The prognosis of FND is usually good 
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There tends to be a perception that in FND ‘nothing is wrong’ or that, with 
treatment, all patients ought to improve. As in any neurological condition, there is a 
spectrum of disease severity treatment response but many studies show the 
majority of patients being the same or worse at follow-up.(8) Patients with FND have 
levels of disability and impairment in quality of life similar to those with similar 
debilitating conditions such as Parkinson’s disease or epilepsy(187) which commonly 
includes chronic pain, fatigue, cognitive problems and psychological comorbidity. 
Lesson: Patients with FND are as disabled and have as impaired quality of life as 
patients with other neurological conditions. When left untreated, prognosis is 
unfavourable for most.
Myth 10: The treatment of FND is solely referral to a psychologist or psychiatrist
FND patients require individualized treatment, beginning with a transparent and 
carefully explained diagnosis. This should avoid simply telling the patient what they 
don’t have or jumping to conclusions about aetiology. Demonstration of positive 
signs to the patient can alter fundamental views about the nature and potential 
reversibility of the condition. As in other neurological conditions a multidisciplinary 
approach is often required for more complex cases.(198) Physical therapy alone is 
effective in some patients with functional movement disorders and has promising 
early data from randomised trials, even in patients with long duration 
symptoms.(2019) There is an evidence base for psychological therapy in functional 
(dissociative) seizures(210) which may also be essential when anxiety, mood, or 
personality disorders are comorbid. Identifying and triaging patients with dominant 
pain or fatigue syndromes is important, as these may need to be the initial focus of 
treatment. In some severe cases, the main treatment focus may be on support and 
prevention of iatrogenic harm from unnecessary medication or interventions.
Lesson: FND treatment is individualized and involves careful explanation 
combinations of physical and psychological rehabilitation.
Conclusion
FND is a common condition, lying at the interface of neurology and psychiatry and is 
best approached from a biopsychosocial perspective.  neurological condition 
encountered in any neurology practice. A clear diagnosis delivered in a timely 
manner can have a strong positive impact on the patient’s symptoms, prognosis, and 
quality of life. Patients can improve with individualized, multidisciplinary treatment. 
Attitudes and practices are changing but the many misconceptions that surround 
FND continue to obstruct good medical care for these patients. 
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The article is a helpful summary of important myths in an easily readable format suitable for the 
general neurologist and will hopefully help challenge those myths.
I had some minor comments only:
This sentence does not quite flow easily; explaining Hoover's sign after hip abductor sign 
(Positive signs on examination include Hoover’s sign or abductor sign of functional limb 
weakness, where hip extension weakness returns to normal when attention is diverted to the 
contralateral leg.
This has now been corrected to:
Positive signs on examination include Hoover’s sign of functional limb weakness, where hip 
extension weakness returns to normal when attention is diverted to the contralateral leg.
For this reason, there should be a low threshold for investigations
As below I feel an addition is important; to have low threshold for investigations but explain 
beforehand that because FND can co-exist investigation findings do not necessarily change 
management; and it can be helpful to explain investigations (especially MRI) can have incidental 
findings; at times after discussion of the incidental findings investigations can be postponed to 
allow clinical monitoring, e.g. in functional cognitive symptoms and mild functional tremor a 
review after 6-12 months can replace investigations if decision regarding investigations are 
shared decisions with patients.
the clinically silent multiple sclerosis or root lesion contributing to the clinical
picture.
Reviewer: I do not see how clinically silent MS contributes to a clinical picture. That is 
radiologically isolated syndrome. It can lead to a clinical picture but as above careful 
conversation before investigation is done can help tremendously in dealing with results of 
investigations. 
We thank the reviewer for these excellent points. We have changed the section to highlight this:
 
Having a low threshold for investigations is important because additional neurological disease, 
such as radiculopathy or demyelination, is such a strong risk factor for FND. Care must be taken 
in explaining to patients why investigations are being done and to prepare the patient for 






























































potentially incidental findings. 
which vary with those seen in experimental feigning.
Reviewer: Is it meant to say: contrasts or differs to those seen?
Yes – thank you for picking this up, the sentence has been corrected.
Lesson: FND is not misdiagnosed more than other conditions. Erroneously
diagnosing FND as another neurological condition can be as harmful as the reverse.
Reviewer: possible relevant reference to: how to undiagnose neurological disease (coebergh et 
al Practical Neurology
We thank the reviewer for this additional reference, which we have now added to the revision.
This sentence does not quite flow:
More recent work shows that a history of adverse life experience and psychological 
comorbidities are
commonly seen in this population, (MISSING: BUT) they do not occur in all patients, and even 
when present may not be relevant.(12)
Agreed – this has been added.
Overall however with minor adjustments on how to decide/explain investigations a helpful, easy 
to read letter for the general neurologist.




I have read this article with interest as the topic of FND is of great importance to the clinical 
neurosciences. This article is well written and I agree with well over 90% of what is being 
conveyed. However, there are some subtle yet very important themes that I do not completely 
agree with and I am hopeful the authors can consider in more nuanced fashion:
1. Myth 5 (minor comment) - it may be helpful to note that abnormal movements in FND are 
perceived as involuntary - however clinical features such as tremor entrainment underscore that 
functional abnormal movements engage volitional motor pathways. 
We agree with this point and have altered the text as follows
“FND symptoms are perceived as involuntary but do arise from the voluntary nervous system which is 
one reason why concerns about exaggeration or malingering may persist in many doctors’ minds when 
thinking about FND”






























































2. Myth 8 (major comment) - is not entirely a myth in my opinion. In some patients, FND is a 
condition where psychological factors are the primary drivers of the disorder (some patients will 
tell us this themselves!). As examples, we can think about patients whose dissociative seizures 
overlap considerably with panic attacks with a heightened tremulousness and a dissociative 
component. We can think of others whose functional neurological symptoms are occurring in 
the context of traumatic re-experiencing events (flashbacks). I think for Myth 8 it is critically 
important to be more nuanced to allow for the importance of neurological and 
psychiatric/psychological viewpoints. The equation for developing FND is highly heterogenous. 
For some patients, psychological factors are the primary driver of the condition. For others, 
medical / neurological factors (TBI and dissociative seizures; peripheral limb injury and 
functional dystonia) may play a stronger role. Where the field has gone wrong previously is 
forcing onto patients certain etiological models when they are not relevant. I don't know the 
cause of FND in any patient, but I do find that patients can find this out for themselves in the 
course of treatment. Sometimes when patients improve they make the psychologically rich 
formulation for themselves and providers. 
3. Related to point 2, the authors note that for some patients psychological factors and life 
events are not relevant for their clinical picture. Why that can be the case in some, for others life 
events are relevant and the correlation between adverse early life events and symptom severity 
offers an alternative perspective of importance (i.e. Roelofs et al AJP 2002; Selkirk et al 2008 
Epilepsia; Perez, Matin et al 2017 JNNP). In addition to edits to the body of this section, a quick 
fix to the Myth 8 statement is to add the word "exclusively" (FND is exclusively a psychological 
problem caused by psychological factors). 
We thank the reviewer for these important comments. We completely agree this should have been 
more nuanced and that very often psychological factors are drivers for symptom generation 
and/or maintenance. Here we were addressing the myth about etiology of FND being exclusively 
“psychological”. The reviewer is correct that we should have added the word ‘exclusively’ to the 
title, and this has been done.
We have also added the following text to the revised manuscript:
“FND is a complex and heterogeneous disorder, with multiple potential biological and 
psychological causes and mechanisms that vary hugely between patients, and which challenges 
conventional dualistic assumptions about the brain and mind. 
Lesson: Psychological factors are one of many possible risk factors for FND and should not be 
considered as the sole etiological cause.”
4. Myth 10 could also be more nuanced. Adding in the qualifier "solely" or "exclusively" would 
more accurately convey the point I think. In some instances, the primary treatment can be 
referral to a psychotherapist with experience in the management of FND. What you are trying to 
convey here (which is so important as well) is that the neurologist plays an important role in 
treatment, including catalyzing treatment engagement. Also - while I've heard many talk about 
how motor FND can improve with physiotherapy alone, this may be true of patients with modest 






























































symptom burden, acute onset and/or low psychiatric comorbidities. The converse is much more 
familiar to me - physical and occupational therapists raising concerns that 
psychiatric/psychological factors are under addressed and impeding treatment 
We agree with the reviewer and have now amended the myth title. Unfortunately, the format of 
this piece requires a simplified discussion of this complex topic. In our experience many patients 
with motor FMD who improve or partially improve with PT, it is not the PT itself that is the helpful 
component, rather the education around FND, the disease model, and self-management strategies 
which are not elements of traditional neurorehabilitation. Thus, the specificity of what is being 
targeted in physical rehab for FND is not yet well understood.
5. The conclusion: I think that statements such as "FND is a common neurological condition" 
unqualified does not send the appropriately nuanced message. Not also pointing out that FND 
"is a common (neuro)psychiatric condition as well" disenfranchises our 
psychiatry/psychology/social work colleagues who are so needed in the front lines of FND 
clinical care (and research). I wonder if the authors can consider rephrasing to note that FND is a 
common condition at the interface of neurology and psychiatry.
We agree, note that we had initially targeted this piece to Neurologists, reflecting the word choice 
here. We take the reviewer’s point and do not want to underemphasize the importance of 
psychiatry, while also asserting the responsibility of the neurologist in daily practice not to over-
estimate the role of psychiatric pathology in these patients. It is a fine line and we have attempted 
to soften this here: 
FND is a common condition, lying at the interface of neurology and psychiatry.
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